Growth Metrics

Edwards Lifesciences (EW) Net Cash Flow Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -32.51%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -87.87%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 42.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -11.49%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -87.88%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -48.90%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 129.29%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -65.12%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 33.47%
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn -51.65%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -87.88%
Dec 31, 2025 36.14%
Sep 30, 2025 -159.30%
Jun 30, 2025 3.58%
Mar 31, 2025 -11.37%
Dec 31, 2024 -1.07%
Sep 30, 2024 120.58%
Jun 30, 2024 42.68%
Mar 31, 2024 71.38%
Dec 31, 2023 -51.07%
Sep 30, 2023 42.36%
Jun 30, 2023 -14.01%
Mar 31, 2023 30.26%
Dec 31, 2022 -340.29%
Sep 30, 2022 -56.23%
Jun 30, 2022 92.64%
Mar 31, 2022 255.62%
Dec 31, 2021 -6.21%
Sep 30, 2021 83.34%
Jun 30, 2021 215.06%
Mar 31, 2021 -27.18%
Dec 31, 2020 -0.53%
Sep 30, 2020 0.60%
Jun 30, 2020 40.64%
Mar 31, 2020 -66.28%
Dec 31, 2019 -26.39%
Sep 30, 2019 18.82%
Jun 30, 2019 29.62%
Mar 31, 2019 74.40%
Dec 31, 2018 -112.89%
Sep 30, 2018 -14.65%
Jun 30, 2018 -67.82%
Mar 31, 2018 62.69%
Dec 31, 2017 -9.81%
Sep 30, 2017 48.81%
Jun 30, 2017 -52.39%
Mar 31, 2017 3.57%
Dec 31, 2016 93.08%
Sep 30, 2016 42.63%
Jun 30, 2016 -52.42%
Mar 31, 2016 -63.72%
Dec 31, 2015 156.50%
Sep 30, 2015 263.19%
Jun 30, 2015 10.06%
Mar 31, 2015 -92.83%
Dec 31, 2014 78.27%
Sep 30, 2014 -48.54%
Jun 30, 2014 49.13%
Mar 31, 2014 -14.21%
Dec 31, 2013 -48.03%
Sep 30, 2013 56.50%
Jun 30, 2013 -58.90%
Mar 31, 2013 865.13%
Dec 31, 2012 -27.84%
Sep 30, 2012 -26.23%